Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C9H15NO3 |
Molecular Weight | 185.2203 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1[C@H]2CC[C@@H]1[C@H]([C@@H](O)C2)C(O)=O
InChI
InChIKey=PHMBVCPLDPDESM-FKSUSPILSA-N
InChI=1S/C9H15NO3/c1-10-5-2-3-6(10)8(9(12)13)7(11)4-5/h5-8,11H,2-4H2,1H3,(H,12,13)/t5-,6+,7-,8+/m0/s1
Molecular Formula | C9H15NO3 |
Molecular Weight | 185.2203 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 4 / 4 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
A catalytic antibody against cocaine attenuates cocaine's cardiovascular effects in mice: a dose and time course analysis. | 2001 Jun |
|
2'-substituted analogs of cocaine: synthesis and dopamine transporter binding potencies. | 2001 Sep |
|
Analysis of cocaine, benzoylecgonine, ecogonine methyl ester, and ecgonine by high-pressure liquid chromatography-API mass spectrometry and application to a short-term degradation study of cocaine in plasma. | 2001 Sep |
|
Synthesis and dopamine transporter binding of 2beta-isopropyl ester analogs of cocaine. | 2002 Feb |
|
Determination of the highest no-effect dose (HNED) and of the elimination pattern for cocaine in horses. | 2002 Mar-Apr |
|
Determination of the dermal penetration of esterom components using microdialysis sampling. | 2003 Nov |
|
Gender differences in cocaine pharmacokinetics in CF-1 mice. | 2005 Jan 15 |
|
Concentration profiles of cocaine, pyrolytic methyl ecgonidine and thirteen metabolites in human blood and urine: determination by gas chromatography-mass spectrometry. | 2005 Nov |
|
Simultaneous analyses of cocaine, cocaethylene, and their possible metabolic and pyrolytic products. | 2006 Feb 10 |
|
Rapid analysis of benzoylecgonine in urine by fast gas chromatography-mass spectrometry. | 2006 Oct |
|
Alpha2-containing GABA(A) receptors are involved in mediating stimulant effects of cocaine. | 2008 Jul |
|
Tropane alkaloids as medicinally useful natural products and their synthetic derivatives as new drugs. | 2008 Jul-Aug |
|
Can cocaine use be evaluated through analysis of wastewater? A nation-wide approach conducted in Belgium. | 2009 May |
|
The hydrated and anhydrous gold(III) tetrachloride salts of L-ecgonine, an important forensic toxicology marker for cocaine. | 2010 Jan |
|
Urinary excretion of ecgonine and five other cocaine metabolites following controlled oral, intravenous, intranasal, and smoked administration of cocaine. | 2010 Mar |
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:05:49 GMT 2023
by
admin
on
Fri Dec 15 15:05:49 GMT 2023
|
Record UNII |
DX2E9E17AV
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
DEA NO. |
9180
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
207-565-4
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DB01525
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
ECGONINE
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
C005617
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DTXSID701019899
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
91460
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
4743
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
481-37-8
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
DX2E9E17AV
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
m4810
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | Merck Index | ||
|
SUB33203
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY | |||
|
100000126157
Created by
admin on Fri Dec 15 15:05:49 GMT 2023 , Edited by admin on Fri Dec 15 15:05:49 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE | |||
|
PARENT -> SALT/SOLVATE |
|
||
|
SALT/SOLVATE -> PARENT |
APPROXIMATE PURE ANHYDROUS DRUG CONTENT (IN PERCENT)
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
SOLVATE->ANHYDROUS |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |